首页> 外文期刊>Pediatric Emergency Medicine Journal >N-terminal Pro-Brain Natriuretic Peptide, Adjuvant Laboratory Marker of Acute Phase of Kawasaki Disease in Emergency Department
【24h】

N-terminal Pro-Brain Natriuretic Peptide, Adjuvant Laboratory Marker of Acute Phase of Kawasaki Disease in Emergency Department

机译:N-terminal Pro-Brain Natriuretic Peptide, Adjuvant Laboratory Marker of Acute Phase of Kawasaki Disease in Emergency Department

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Diagnosis of Kawasaki disease (KD) in emergency department (ED) is sometimes difficult because of unsatisfied diagnostic criteria, especially when febrile days are less than 5 days. Clinical and laboratory features may be helpful in establishing the diagnosis in these cases. N-terminal pro-brain natriuretic peptide (NT-proBNP) has been proved as a laboratory indicator for identifying patients with KD, but usefulness in ED has not been studied. Methods: NT-proBNP levels obtained from patients who were suspected as KD at present in ED, from January 1, 2011 to December 31, 2013. The patients were divided into KD with less than 5 febrile days and other febrile disease group according to final diagnosis. The difference of each group, thesensitivity and specificity of NT-proBNP value were analyzed. Results: In the group of less than 5 febrile days, NT-proBNP levels were significantly higher in the KD patients (P=0.01). In the receiver operating characteristic curve analysis in the group of less than 5 febrile days, the sensitivity was 62.5, and the specificity was 77.7 at 105.5 pg/mL of NT-proBNP level. Conclusion: We expect that NT-proBNP would be a useful adjuvant diagnostic tool for KD patients with atypical clinical presentations, especially in cases with less than 5 febrile days.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号